Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-87,719
Closed -$7.96M 1526
2024
Q4
$7.96M Buy
87,719
+81,532
+1,318% +$7.49M 0.09% 347
2024
Q3
$597K Buy
6,187
+951
+18% +$92.8K 0.01% 1206
2024
Q2
$481K Sell
5,236
-9,730
-65% -$903K 0.01% 1256
2024
Q1
$1.38M Buy
+14,966
New +$1.4M 0.03% 792
2022
Q4
Sell
-3,164
Closed -$306K 1346
2022
Q3
$306K Buy
3,164
+395
+14% +$47.1K 0.01% 1027
2022
Q2
$291K Buy
+2,769
New +$354K 0.01% 1138
2021
Q2
Sell
-1,829
Closed -$484K 1060
2021
Q1
$484K Buy
+1,829
New +$516K 0.04% 521
2020
Q4
Sell
-4,865
Closed -$1.15M 996
2020
Q3
$1.15M Buy
+4,865
New +$1.11M 0.07% 368
2019
Q2
Sell
-2,933
Closed -$362K 773
2019
Q1
$362K Sell
2,933
-19,710
-87% -$2.47M 0.03% 680
2018
Q4
$2.65M Buy
+22,643
New +$2.67M 0.17% 178
2018
Q2
Sell
-6,277
Closed -$379K 875
2018
Q1
$379K Sell
6,277
-11,547
-65% -$658K 0.03% 723
2017
Q4
$940K Buy
+17,824
New +$939K 0.1% 309
2017
Q1
Sell
-8,890
Closed -$379K 1056
2016
Q4
$379K Buy
+8,890
New +$378K 0.06% 551
2016
Q1
Sell
-26,211
Closed -$1.03M 890
2015
Q4
$1.03M Buy
+26,211
New +$1.05M 0.09% 382
2015
Q3
Sell
-5,600
Closed -$222K 1013
2015
Q2
$222K Sell
5,600
-12,500
-69% -$389K 0.02% 897
2015
Q1
$484K Buy
+18,100
New +$511K 0.05% 702

Other funds holding AMED

Trexquant Investment's AMED Position: Q1 2025 in Review

Trexquant Investment sold out of Amedisys (AMED) in Q1 2025, closing a stake of 87,719 shares — an estimated $7.96M sold.

Trexquant Investment first reported a position in AMED in Q1 2015 and held it in 16 quarters. The position peaked at $7.96M in Q4 2024. 304 funds tracked by Wall St. Rank hold AMED as of Q1 2025.

  • Trexquant Investment reported no remaining Amedisys position as of Q1 2025 after selling out during the quarter.
  • Trexquant Investment sold 87,719 Amedisys shares in Q1 2025, an estimated $7.96M.
  • Trexquant Investment first reported a position in Amedisys in Q1 2015 and held it in 16 quarters.
  • Trexquant Investment's Amedisys position peaked at $7.96M in Q4 2024.
  • 304 funds tracked by Wall St. Rank held Amedisys as of Q1 2025.

Based on Trexquant Investment's 13F filing for Q1 2025, filed 14 May 2025.